/PRNewswire/ The Global Health Innovative Technology (GHIT) Fund announced today an investment totaling approximately 260 million yen (US$1.9 million1) for.
/PRNewswire/ The Global Health Innovative Technology Fund (GHIT Fund) and global health agency Unitaid have signed a cooperation framework that aims to.
Arpraziquantel is the first investigational drug in regulatory phase amongst the different projects supported by the GHIT (Global Health Innovative Technology).
/PRNewswire/ The Global Health Innovative Technology (GHIT) Fund announced today that it has secured a pledge from global charitable foundation Wellcome for.